We can’t show the full text here under this license.
Abstract
GLP-1 receptor agonists (GLP-1RAs) may offer therapeutic potential for metabolic dysfunction-associated fatty liver disease.
- GLP-1RAs are already transforming the management of type 2 diabetes mellitus.
- They may provide cardiovascular and renal protective effects, particularly in diabetic kidney disease alongside certain medications.
- There is evidence suggesting potential benefits for bone health in diabetic osteoporosis.
- GLP-1RAs could have neuroprotective properties that may aid in the treatment of Alzheimer's disease by affecting insulin signaling in neurons.
- Improvements in hormonal and metabolic profiles in polycystic ovary syndrome have been associated with the use of GLP-1RAs.
- Ongoing research is necessary to fully understand the broad therapeutic effects of GLP-1RAs across various systemic diseases.
Simplified